340B Health

340B Hospital Group Responds to Misleading Report from Big Pharma

in 340B Health News Releases

For Immediate Release                
Tuesday March 25, 2014     

Contact: Randy Barrett

340B Hospital Group Responds to Misleading Report from Big Pharma

In its continued public relations campaign to discredit the 340B drug discount program, the pharmaceutical industry has financed another study that intentionally misrepresents its purpose. This report goes a step further by suggesting that many hospitals don’t deserve to be in the program based on a narrow and misleading interpretation of care to needy patients.

From the most urban areas to the most remote parts of our country, 340B is enabling patients to access affordable medication and other critical health care services. 

“We treat many underserved patients in Detroit and the surrounding communities of southeast Michigan,” says Robert Chapman, M.D., Director of the Josephine Ford Cancer Institute at the Henry Ford Health System. "We provide $233 million in charity care and uncompensated care each year," says Chapman.  "Savings achieved through 340B are critically important in helping us offset these shortfalls and allowing us to continue to serve these patients.”

340B Health is an association of more than 1,000 hospitals with a mission to increase the affordability and accessibility of pharmaceutical care for the nation's poor and underserved populations. For more information about 340B Health and the 340B program, visit www.340bhealth.org

340B Health Bulletin 340B Health Update